
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
In the highly regulated global biopharmaceutical supply chain, compliance and quality of chromatography media are mission-critical. To meet the technical filing requirements of regulatory authorities such as the U.S. FDA and European EMA, Sunresin has been actively advancing Drug Master File (DMF) registration for its life science-grade chromatography products, and has made significant progress.
As of today, Sunresin has obtained DMF numbers for 10 chromatography products, with another 9 under active review, covering a wide range of chromatographic modes including ion exchange, affinity, mixed-mode, and hydrophobic interaction. These DMF-registered products help pharmaceutical customers accelerate regulatory submissions across global markets.

What is a DMF and Why Does It Matter?
A Drug Master File (DMF) is a confidential technical dossier submitted to regulatory agencies such as the FDA and EMA. It contains detailed information on raw materials, manufacturing processes, analytical methods, and quality controls.
For chromatography media used in the production of antibody drugs, vaccines, and gene therapies destined for the U.S. or European markets, DMF registration serves as a crucial “passport” for market entry.
Benefits for biopharma companies:
✅ Simplifies regulatory filings (IND, BLA, NDA) by referencing the DMF number
✅ Eliminates the need to resubmit raw material and quality documents
✅ Serves as authoritative proof of GMP and pharmacopeia compliance
DMF-Registered Products (Selection):
Below is a sample list of chromatography products that have obtained DMF registration numbers to date.
_1751358058_WNo_4128d2068.webp)
Sunresin: Beyond Materials, A Partner in Bioprocess Solutions
With over 20 years of experience in chromatography resin development and biopharmaceutical manufacturing, Sunresin operates a mature GMP-compliant production platform and serves customers across global markets.
We are more than a material supplier — we provide full-spectrum support including:
- Regulatory-compliant raw material & process design
- DMF filing documentation and assistance with customer submissions
- IND/NDA project coordination support
- Customized chromatography solutions for monoclonal antibodies, vaccines, and gene therapies
Looking Ahead
Sunresin will continue to expand its DMF-registered product portfolio and strengthen its global regulatory framework. We are committed to delivering high-quality, compliant, and efficient solutions to support the innovation of life science companies worldwide.
Choose Sunresin. Empower global biologics with high-performance chromatography materials made in China. Together, we advance the future of life sciences.
Free Quote
Resources
Adsorbent Resin
Bio-Pharmaceutical & Life Science
Enzyme Carriers
Hydrometallurgy & Mining
Chelating Resin
Chemical Industry
Chromatographic Media
Wastewater Treatment&Reuse
Food & Beverage Industries
Ion Exchange Resin
Civil & Industry Water Treatment
Equipments And Projects
Plant Extraction
Catalyst Resin
Solid Phase Peptide Synthesis
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
11
2025 04
SZSE Visits Sunresin – An ETF Constituent Company in the CSI 500 Index
On the morning of March 28, the Shenzhen Stock Exchange (SZSE), along with representatives from Harvest Fund and over 30 other participants, visited Sunresin— a constituent company of the CSI 500 Index — for a special research and engagement activity.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit